Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Safiglipron

Phase III Study of HRS-7535 for Hypertension With Overweight or Obesity

Shandong Suncadia Medicine Co · Phase 3 · Recruiting · Enrollment 648

NCT07528027

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
Treatment group A: HRS-7535n/rn/rn/rn/r
Treatment group B: Placebon/rn/rn/rn/r

Not shown

  • Treatment group A: HRS-7535: endpoint not reported
  • Treatment group B: Placebo: endpoint not reported